Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

09 December 2020

The threat of antibiotic resistance — in charts

Andrew Jack and Chris Campbell for the Financial Times look at government and nonprofit efforts to track antibiotic overuse and antimicrobial resistance.

Direct links

Read the full article

In this article, the authors compile data from the Access to Medicine Foundation, the Centre for Disease Dynamics, Economics and Policy (CDDEP), Pew Charitable Trusts, and The Farm Animal Investment Risk & Return initiative (FAIRR) to highlight the challenges created by antibiotic overuse both in humans and in animals farmed for food. The authors illustrate the issues with the use of charts and graphs from these organisations.

The authors note that while efforts to measure trends in antibiotic use have been historically limited, programmes such as the Access to Medicine Foundation's Antimicrobial Resistance Benchmark, along with other government and nonprofit initiatives, work to track antibiotic usage and encourage action against antimicrobial resistance.

The authors write that the Foundation's Antimicrobial Resistance Benchmark "tracks the activities of pharmaceutical companies on antimicrobial resistance, providing a tool for investors and policymakers." They quote the Benchmark report, noting that “the pace of change in 2020 does not match the scale of the AMR challenge”.

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved